WAKEFIELD, MA – February 18, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, announced today the Company is exploring its lead defensin mimetic drug candidate, Brilacidin, as a potential novel coronavirus treatment.
Over the last few weeks, the Company has received inquiries asking about Brilacidin’s potential to treat the Coronavirus given the urgent worldwide need to find effective treatments for this deadly epidemic.
Maybe LW put the word out. Interesting Leo terms it "over the last few weeks". So this had been a back and fourth for awhile.